课题基金 / 基金详情

Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use

Mechanism-based serum biomarkers and validation of ensemble model for excessive alcohol use
基于机制的血清生物标志物和过量饮酒整体模型的验证
批准号:
10426278
负责人:
Suthat Liangpunsakul
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-10-01 至 2025-12-31

项目摘要

项目成果

Suthat Liangpunsakul的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Increasing the sensitivity and specificity of biomarkers for recognizing recent, excessive alcohol use (EAU) in Veterans is a timely goal of research. EAU is becoming recognized as an emerging health-related problem especially among veterans returning from combats. As such, there is a need for increased vigilance and action to identify and counsel at-risk veterans. The diagnosis and care of veteran patients with EAU is hampered by the lack of tests with high diagnostic performance that can detect dangerous levels of drinking or relapse during therapy. Such tests would be indispensable for screening and care for veterans with EAU. The consequences of under-detection of EAU, thus delayed intervention are serious because relative risk of alcohol- related health conditions is increased with the amounts and duration of alcohol consumed per day. Excessive alcohol use (EAU) is becoming recognized as an emerging health-related problem especially among veterans returning from combats. Our preliminary data using the new landscape of proteomic and transcriptomic approaches have uncovered the pathophysiology of EAU on several pathways; which might lead to pathology in human. This renewal CSR&D Merit Review Award application seeks the support to define the roles of the panels of biomarkers; derived from the effect of EAU on inflammatory response to screen for EAU and quantity of recent alcohol consumption and monitoring for abstinence. We hypothesize that (i) these biomarkers derived from system biology analyses are useful and have a better diagnostic performance to screen for EAU and the quantity of recent alcohol consumption in clinical practice, when compared to the conventional markers and (ii) the combination of these markers into a single risk model prediction using machine learning and statistical mechanics will revolutionize the way we screen for EAU in clinical practice. To test this hypothesis, we plan to pursue the following specific aims; SPECIFIC AIM # 1: Determine the effect of EAU on organ system identified by system biology approach and by detecting, identifying, and comparing the relative quantity of these novel targets as potential biomarkers for EAU, and SPECIFIC AIM # 2: To develop and validate of a risk model for prediction of EAU combining aspects of machine learning and statistical mechanics. If successful, the results from this project will revolutionize the screening methods for veterans with excessive alcohol use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FKBP5 in the pathogenesis of alcohol-associated liver disease
FKBP5 in the pathogenesis of alcohol-associated liver disease
S-adenosylmethionine treatment in alcoholic cirrhosis
S-adenosylmethionine treatment in alcoholic cirrhosis
海外基金